Raymond James Financial
RVMD icon

Raymond James Financial’s Revolution Medicines RVMD Stock Holding History

Raymond James Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.7M Buy
174,434
+37,274
+27% +$5.44M 0.01% 1220
2026
Q1 		$13.3M Sell
137,160
-107,014
-44% -$10.8M ﹤0.01% 1780
2025
Q4 		$19.4M Sell
244,174
-33,986
-12% -$2.23M 0.01% 1459
2025
Q3 		$13M Sell
278,160
-17,059
-6% -$668K ﹤0.01% 1724
2025
Q2 		$10.9M Sell
295,219
-8,398
-3% -$323K ﹤0.01% 1802
2025
Q1 		$10.7M Sell
303,617
-17,994
-6% -$730K ﹤0.01% 1760
2024
Q4 		$14.1M Buy
+321,611
New +$16.2M 0.01% 1584

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Raymond James Financial's RVMD Position: Q2 2026 in Review

Raymond James Financial increased its Revolution Medicines (RVMD) stake by 27% in Q2 2026, buying an estimated $5.44M and bringing the position to 174,434 shares worth $32.7M. The position accounts for 0.01% of the portfolio, ranked #1220.

Raymond James Financial first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Raymond James Financial held 174,434 shares of Revolution Medicines worth $32.7M as of Q2 2026.
  • Raymond James Financial bought 37,274 Revolution Medicines shares in Q2 2026, an estimated $5.44M.
  • Revolution Medicines made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1220 holding.
  • Raymond James Financial first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.